SecProbe.io

Probe score transparency
Intelligence Terminal Search Topics Monthly Activity About

Probe Score Transparency

Aspire Biopharma Holdings, Inc. (ASBP)
Score window: May. 30, 2025 to May. 29, 2026

Back View Correspondence
Probe Score
2.5 / 10
Letters
2
Latest Activity
Apr. 13, 2026
Version
v1

Score Breakdown

Letter Count
2.0
Sentiment / Tone
0.5
Keywords
0.0
Signals
0.0
Notable 8-K Modifier
0.0
Notable 8-K Count
0

Matched Signals

No stored keyword or signal matches were recorded for this score.

Filings In This Window

DateFormSentimentUrgencySummaryOpen
Apr. 13, 2026 CORRESP Neutral/Informational Moderate Aspire Biopharma Holdings, Inc. has submitted a request to the SEC to accelerate the effective date of their Registration Statement on Form S-1. They are seeking for it to be decl… Read Filing EDGAR
Feb. 24, 2026 UPLOAD Neutral/Informational Low The SEC has communicated to Aspire Biopharma Holdings, Inc. that they will not review the company's registration statement filed on February 17, 2026. The SEC emphasizes that the … Read Filing EDGAR
Sep. 26, 2025 CORRESP Neutral/Informational Moderate Aspire Biopharma Holdings, Inc. has submitted a request to the SEC to accelerate the effective date of their Registration Statement on Form S-1. They are seeking to have it declar… Read Filing EDGAR
Sep. 24, 2025 UPLOAD Neutral/Informational Low The SEC has communicated to Aspire Biopharma Holdings, Inc. that it will not review their registration statement filed on September 18, 2025. The letter emphasizes the company's r… Read Filing EDGAR

Notable 8-Ks In This Window

No notable 8-Ks were stored for this company in the score window.